Glynn, S.E.; Lanier, C.M.; Choi, A.R.; D’Agostino, R., Jr.; Farris, M.; Abdulhaleem, M.; Wang, Y.; Smith, M.; Ruiz, J.; Lycan, T.;
et al. Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers 2025, 17, 991.
https://doi.org/10.3390/cancers17060991
AMA Style
Glynn SE, Lanier CM, Choi AR, D’Agostino R Jr., Farris M, Abdulhaleem M, Wang Y, Smith M, Ruiz J, Lycan T,
et al. Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers. 2025; 17(6):991.
https://doi.org/10.3390/cancers17060991
Chicago/Turabian Style
Glynn, Sarah E., Claire M. Lanier, Ariel R. Choi, Ralph D’Agostino, Jr., Michael Farris, Mohammed Abdulhaleem, Yuezhu Wang, Margaret Smith, Jimmy Ruiz, Thomas Lycan,
and et al. 2025. "Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?" Cancers 17, no. 6: 991.
https://doi.org/10.3390/cancers17060991
APA Style
Glynn, S. E., Lanier, C. M., Choi, A. R., D’Agostino, R., Jr., Farris, M., Abdulhaleem, M., Wang, Y., Smith, M., Ruiz, J., Lycan, T., Petty, W. J., Cramer, C. K., Tatter, S. B., Laxton, A. W., White, J. J., Su, J., Whitlow, C. T., Soto-Pantoja, D. R., Xing, F.,
... Helis, C. A.
(2025). Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? Cancers, 17(6), 991.
https://doi.org/10.3390/cancers17060991
